ライフサイエンスコーパス: cell-mediated

1 Rejections after conversion were mostly cell-mediated.

2 ations to the myofiber through a muscle stem cell-mediated accumulation of total myonuclei and a conc

3 We demonstrate that the magnitude of NK cell-mediated ADCC responses is predominantly influenced

4 wnregulating CD4, were all susceptible to NK cell-mediated ADCC.

5 ncrease of cf-mt-DNA that promotes dendritic cell-mediated, age-specific inflammatory responses.

6 Nickel is the most frequent cause of T cell-mediated allergic contact dermatitis worldwide.

7 revealed a strong sensitization, proving a T cell mediated allergy to budesonide.

8 ced both a complete antitumor response and T cell-mediated allograft rejection requiring reinitiation

9 t the deregulation of pathways involved in T cell-mediated allorecognition is a distinctive feature a

10 al supervision to monitor and treat IgE mast cell-mediated anaphylaxis.

11 determine whether Tregs suppress effector T cell-mediated and inflammatory cytokine-induced CEnC dea

12 acity in protecting CEnCs against effector T cell-mediated and interferon-gamma and tumor necrosis fa

13 rformance of the kSORT assay to detect AR (T cell-mediated and/or antibody-mediated rejection) as com

14 tend to occur later, may be associated with cell-mediated and/or antibody-mediated rejection, and po

15 ta showing islet beta-cell dysfunction and T cell-mediated anti-beta-cell-specific autoimmunity.

16 demonstrate that NKTR-214 synergizes with T cell-mediated anti-cancer therapies.

17 tly, therapeutic blockade of PD-1 enhances T cell-mediated anti-tumor immunity, but many patients do

18 cancer cells and are important targets of T cell-mediated anti-tumor immunity.

19 y upregulating PD-1 ligands and preventing T cell-mediated anti-tumor responses.

20 gs define PTPN2 as a target for bolstering T-cell-mediated anti-tumour immunity and CAR T-cell therap

21 eckpoint blockade synergistically enhanced T cell-mediated anti-tumour immunity and induced ferroptos

22 y we investigated the interplay between MAIT cell-mediated antibacterial effector functions and the h

23 munoparalysis is defined by diminished CD8 T cell-mediated antitumor immunity that can respond to tim

24 " tumors to hot, generates systemic CD8(+) T cell-mediated antitumor immunity, and sensitizes resista

25 y upon endosomal pH activation, leading to T cell-mediated antitumor immunity.

26 l of blocking Chop or ER stress to unleash T cell-mediated antitumor immunity.

27 by unleashing both T and natural killer (NK) cell-mediated antitumor responses.

28 ell surface, where it functions to stimulate cell-mediated antiviral responses.

29 T-cell-mediated approaches have shown promise in myeloma t

30 nsight into the pathogenic mechanisms of a T cell-mediated autoimmune condition.

31 reduced neuropathology in the classic CD4+ T cell-mediated autoimmune disease experimental autoimmune

32 Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease in which the insulin-pr

33 RAbo), effectively blocked the course of a T cell-mediated autoimmune disease.

34 Type 1 diabetes is the prototypical CD4 T cell-mediated autoimmune disease.

35 Multiple sclerosis (MS) is a putative T cell-mediated autoimmune disease.

36 duced stage and a new mechanism underlying B cell-mediated autoimmune diseases such as MS.

37 en (HLA) locus is strongly associated with T cell-mediated autoimmune disorders.

38 d opioids attenuate inflammation in murine T cell-mediated autoimmunity models.

39 r therapeutic activity in a mouse model of T cell-mediated autoimmunity that mimics multiple sclerosi

40 onger insights into the biology underlying B cell-mediated autoimmunity.

41 osis of activated T cells, and can control T-cell-mediated autoimmunity.

42 nt bone marrow failure disorders linked to T-cell-mediated autoimmunity; they are associated with an

43 a gut-resident pathogen by inhibiting goblet cell-mediated bacterial translocation.

44 ffusion of the pollutant substrates into the cell, mediated by specialised outer membrane (OM) channe

45 f cases the translocation occurs in mature B cells mediated by activation-induced cytidine deaminase.

46 Adherence to host intestinal cells mediated by ETEC fimbriae is believed to be a crit

47 nslocation is mainly acquired in precursor B cells mediated by recombination-activating genes in both

48 nates a DNA repair dependency in KRAS-mutant cells, mediated by a network containing BRCA1.

49 ls and their subsequent delivery into cancer cells, mediated by transferrin receptors, in a complex b

50 eta (TGF-beta) suppresses T helper 2 (T(H)2)-cell-mediated cancer immunity(9), we show that blocking

51 checkpoint P2X7 may be targeted to enhance T-cell-mediated cancer immunotherapy and improve T effecto

52 Atopic Dermatitis (AD) is a T cell-mediated chronic skin disease and is associated wit

53 deficient T cells were less able to induce T cell-mediated colitis.

54 genesis in a turbidity assay and upregulates cell-mediated collagen compaction and reorganization, wh

55 hich the antigens are intracellular (often T cell-mediated) compared with disorders in which the anti

56 oped as a targeted therapy for treating Th17 cell mediated conditions.

57 cDC is not required for CD4(+) regulatory T cell-mediated control of colitis.

58 okine-induced antiproliferative effects in T-cell-mediated control of tumor progression.

59 tibility of surviving cancer cells to CD8+ T cell-mediated control through enhanced MHC-I expression.

60 Antibody-dependent cell-mediated cytotoxic activity against FRalpha is also

61 ogramming nanoparticles led to a significant cell-mediated cytotoxic immune response with systemic ef

62 Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important mechan

63 Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important pathwa

64 s (FcgammaRs) and mediate antibody-dependent cell-mediated cytotoxicity (ADCC) may play a dominant ro

65 bola viruses and elicited antibody-dependent cell-mediated cytotoxicity (ADCC) responses against EBOV

66 nctional capability of inducing Ab-dependent cell-mediated cytotoxicity (ADCC), complement deposition

67 reased ability to mediate antibody-dependent cell-mediated cytotoxicity (ADCC), during HCV infection

68 ing to infected cells, or antibody-dependent cell-mediated cytotoxicity (ADCC).

69 Ag, with some mAbs endowed with Ab-dependent cell-mediated cytotoxicity activity.

70 or functional activities (antibody-dependent cell-mediated cytotoxicity and antibody-dependent cell-m

71 ement, Increased IFN-gamma secretion, and NK cell-mediated cytotoxicity and higher percentages of CD8

72 Antibody-dependent cell-mediated cytotoxicity and tier 1 neutralizing-antib

73 or as an important resistance mechanism to T cell-mediated cytotoxicity for TNBC cells.

74 In addition, CD8+ T cell-mediated cytotoxicity has not been linked to parasi

75 and MICB genes related to antibody-dependent cell-mediated cytotoxicity were identified in tumors wit

76 ural killer (NK) cells by antibody-dependent cell-mediated cytotoxicity, both RIFIN and MHC are recru

77 e often associated with inherited defects in cell-mediated cytotoxicity, serves as a prototypical CSS

78 ed robust, cross-reactive antibody-dependent cell-mediated cytotoxicity-mediating and neuraminidase-i

79 Avelumab (anti-PD-L1) induces NK cell-mediated cytotoxicity.

80 hanced T-cell infiltration into tumors and T-cell-mediated cytotoxicity.

81 attenuated Necl-5 binding and natural killer cell-mediated cytotoxicity.

82 mediated immune tolerance and lower CD8(+) T-cell-mediated cytotoxicity.

83 gs are resistant to human humoral rejection, cell-mediated damage and pathogenesis associated with dy

84 m that recreates genetic susceptibility to T-cell-mediated damage.

85 that promotes fibrin degradation, thwarts T cell-mediated defense against fully virulent Y. pestis I

86 t Pla functions to thwart fibrin-dependent T cell-mediated defense against plague.

87 l autoimmune encephalomyelitis is a CD4(+) T cell-mediated demyelinating disease of the CNS that serv

88 D4(+) T cell response and augmented CD8(+) T cell-mediated destruction of the cancer cells in vitro a

89 paracrine-signalling events, such as tumour-cell-mediated differentiation of macrophages and macroph

90 sing rheumatoid arthritis as an example of T cell mediated disease, we demonstrate interactions of ex

91 ounting evidence that IBM is an autoimmune T cell-mediated disease provides hope that future therapie

92 autoimmune myocarditis (TnI-AM), a CD4(+) T-cell-mediated disease, was induced in mice lacking all 3

93 upts autoreactive B cell anergy and causes B cell-mediated diseases by modulating BCR signaling.

94 nhibition might have a therapeutic role in T cell-mediated diseases, including atopic dermatitis (AD)

95 a novel therapeutic target for treating Th17 cell-mediated diseases.

96 s, promote colonic health, and suppress mast cell-mediated diseases.

97 ically contributes to the development of Th2 cell-mediated disorders, most likely by influencing IFNg

98 r controlling CSR, B cell homeostasis, and B cell-mediated disorders.

99 clerosis, neuromyelitis optica, and CD4(+) T cell-mediated disorders.

100 f light chain fibrils, a potential method of cell-mediated dissolution, amyloid-like fibrils were lab

101 Delayed-type, T cell-mediated, drug hypersensitivity reactions are a ser

102 Natural Killer (NK) cell-mediated early innate defense responses to influenz

103 notherapies in breast cancer through a tumor cell mediated effect.

104 ization are important determinants of CD8+ T cell-mediated efficacy against SIV.

105 nity for NKp30 and significantly improved NK cell-mediated, EGFR-dependent killing of tumor cells com

106 by protecting them from natural killer (NK) cell-mediated elimination.

107 dered the cancer cells more susceptible to T cell-mediated elimination.

108 T cells, but not CD4 cells or natural killer cells, mediated elimination of KPC-Par-1(KO) tumor cells

109 h translated into sub-nanomolar gammadelta T-cell-mediated eradication of bladder cancer cells in vit

110 to directly test the survival value of the M cell-mediated escapes and to show that the absence of th

111 ingly unclear: An actual survival value of M cell-mediated escapes has never been supported experimen

112 on in VAT Treg cells, and consequential Treg-cell-mediated generation of 15-keto PGE(2) suppressed co

113 ys was the most prominent, suggesting that T cell-mediated graft rejection could be the cause of the

114 ical features and tissue manifestations of T-cell-mediated graft-versus-host disease.

115 Ex vivo, mast cell-mediated histamine release and degranulation was au

116 Interestingly, the FcgammaRIIIA(+) CD8 T cells mediated HIV-specific Ab-dependent cellular cytoto

117 novel role of B cells as regulators of CD8 T cell-mediated host resistance and memory CD8 T cell form

118 D-scidIL2Rgamma(null) (NSG) mouse model of T-cell-mediated human islet allograft rejection and develo

119 ed in type IV (also termed delayed-type or T cell-mediated) hypersensitivity reactions in response to

120 rly during development, durably influences T cell mediated immune responses across the lifespan.

121 Glycoprotein E (gE)-specific humoral and cell-mediated immune (CMI) responses and the correlation

122 Persistence of humoral and cell-mediated immune (CMI) responses to 2 initial RZV do

123 pressing wild-type HA sequences (wt-HAI) and cell-mediated immune (CMI) responses.

124 cted tissue is critical for optimal CD8(+) T cell-mediated immune protection.

125 function in ovariectomized mice and prevent cell-mediated immune rejection in immune competent mice.

126 e we investigate the impact of HOPE on the T cell-mediated immune response following kidney transplan

127 T cell-mediated immune response plays a crucial role in co

128 osal antibody profile, and a more consistent cell-mediated immune response profile compared with CTH5

129 A modest and balanced cell-mediated immune response specific for the glycoprot

130 ulted in modest, significant boosting of the cell-mediated immune response to Ag85A (p = 0.027; 95% C

131 ining lymph nodes, subsequently initiating T cell-mediated immune response.

132 ability of gluten proteins to stimulate a T-cell-mediated immune response.

133 t peptide MHC (pMHC) ligands initializes the cell-mediated immune response.

134 -CoV-2-S induces robust systemic humoral and cell-mediated immune responses and protects against lung

135 an important endogenous function of MDR1 in cell-mediated immune responses and suggest that ongoing

136 ysical interactions; moreover, they induce T-cell-mediated immune responses critical to psoriasis.

137 This review summarizes the role of cell-mediated immune responses in CHIKV pathogenesis, wi

138 ested a protective role for both humoral and cell-mediated immune responses in recovery from COVID-19

139 Humoral and cell-mediated immune responses persisted above baseline

140 s population, a comprehensive examination of cell-mediated immune responses remains lacking.

141 Little is known about cell-mediated immune responses to natural influenza infe

142 l responses can drive protective humoral and cell-mediated immune responses(2) and might reduce the p

143 ervoir, reactivating the virus, and boosting cell-mediated immune responses.

144 ncer risk was observed for higher FOXP3(+) T-cell-mediated immune tolerance and lower CD8(+) T-cell-m

145 The CMV-specific cell-mediated immunity (CMI) at baseline and at differen

146 lue of monitoring pretransplant CMV-specific cell-mediated immunity (CMI) using an interferon-gamma r

147 CMV cell-mediated immunity (CMV-CMI) as determined by a pept

148 We compared varicella-zoster virus cell-mediated immunity (VZV-CMI) of adults >=70 years wh

149 infection, further confirming that CD4(+) T cell-mediated immunity against Brucella is inhibited by

150 s into myeloid cells that activated CD8(+) T cell-mediated immunity against cancer.

151 tations, identify key molecules required for cell-mediated immunity against EBV, and develop immunoth

152 e essential for cross-presentation and CD8 T cell-mediated immunity against intracellular pathogens a

153 g lung adenocarcinoma development leads to T cell-mediated immunity and disease restraint.

154 These results confirm the role of cell-mediated immunity and highlight the importance of C

155 the ability of B cells to suppress CD4(+) T cell-mediated immunity and modulate CD4(+) T cell effect

156 s LL-CFA/I, may be harnessed to restrict Th1 cell-mediated immunity and protect against T1D.

157 Cell-mediated immunity can eliminate cancer cells and pr

158 es immunosuppressive mechanisms that alter T-cell-mediated immunity in AML.

159 An improved understanding of human T cell-mediated immunity in COVID-19 is important for opti

160 ul experimental approach to directly study T-cell-mediated immunity in vivo In the rhesus macaque AID

161 Cell-mediated immunity is a specific target of several m

162 Although cell-mediated immunity is critical, increasing evidence

163 T cell-mediated immunity is governed primarily by T cell r

164 ed, or where conventional adaptive and/or NK cell-mediated immunity is suppressed.

165 KG2D-driven regulation of CD4+ T helper (Th) cell-mediated immunity remains unclear.

166 nfection may modulate the establishment of T cell-mediated immunity, adversely affecting long-term pr

167 immune cross-protection, improve humoral and cell-mediated immunity, and promote antigen dose sparing

168 ta deletion does not impair overall CD8(+) T cell-mediated immunity, including antiviral immunity, im

169 that regulate the quality and magnitude of T cell-mediated immunity, known as tolerance checkpoints.

170 Supported by a mixed Th1/Th2 cell-mediated immunity, P27A induced a marked specific a

171 Adult frogs possess efficient conventional T cell-mediated immunity, whereas tadpoles predominantly r

172 Although presumed to induce T cell-mediated immunity, whether tumor elimination depend

173 l and macrophage populations contribute to T cell-mediated immunity.

174 to the biology of the cell and mechanisms of cell-mediated immunity.

175 function when operating in conjunction with cell-mediated immunity.

176 ew insights into how CRAC channels control T cell-mediated immunity.

177 th cytokines are essential in regulating Th1 cell-mediated immunity.

178 ized by hypergammaglobulinemia and defective cell-mediated immunity.

179 gen re-stimulation, suggesting activation of cell-mediated immunity.

180 nfluenza vaccine that induces antibodies and cell-mediated immunity.

181 pathway (MHC-I APP), promoting evasion of T cell-mediated immunity.

182 the induction and maintenance of humoral and cell-mediated immunity.

183 arget of interest in efforts to manipulate T cell-mediated immunity.

184 f vaccination strategies intended to provoke cell-mediated immunity.

185 not influence their ability to orchestrate T cell-mediated immunity.

186 s well as for designing vaccines that elicit cell-mediated immunity.IMPORTANCE The high morbidity and

187 SAEs), biochemical/hematological parameters, cell-mediated immunogenicity by enzyme-linked immunospot

188 udies have suggested an important role for T-cell-mediated immunopathology in LF pathogenesis, but th

189 twork with SATB1 and is important for T(reg) cell-mediated immunosuppression.

190 receptor programmed cell death 1 promotes T-cell-mediated immunosurveillance against tumours, and ha

191 ling promotes PD-L1 expression to suppress T cell-mediated immunosurveillance.

192 supporting immunoevasion and in subverting T cell-mediated immunosurveillance.

193 bly reduced, which further facilitated the T cell mediated immunotherapy.

194 Nearly 20 years ago, NK cell-mediated immunotherapy emerged as a safe and effect

195 The systemic tumor-specific and cell-mediated immunotherapy response was achieved withou

196 3 (and not CXCR3CXCR5) OVA-primed OT-I CD8 T cells mediated in vivo suppression of anti-OVA antibody

197 eliorates symptoms of EAE by decreasing Th17 cell-mediated inflammation and demyelination.

198 Yet, T cell-mediated inflammation and host defense against Citr

199 w, we focus on the characteristics of immune cell-mediated inflammation in islets and the consequence

200 iscovered IgGs heighten pain indirectly by T-cell-mediated inflammation or destruction of targets wit

201 ted bone resorption and attenuates dendritic cell-mediated inflammation through impairing acidificati

202 ased iNKT cell levels and resistance to iNKT cell-mediated inflammatory conditions.

203 its organ sequelae show characteristics of T cell-mediated inflammatory diseases.

204 upporting remyelination by promoting myeloid cell-mediated inflammatory responses via TNF-alpha, whic

205 ation of Ctsk dramatically reduced dendritic cell-mediated inflammatory signaling.

206 utes likely tune the extent of neurogliaform cell mediated inhibition thus constituting canonical cir

207 hestrated suppression of natural killer (NK) cell-mediated innate antitumor immunity, leading to incr

208 ed through an antibody-mediated adaptive and cell-mediated innate immune response.

209 Here we show that STAT1 enables CD4(+) T-cell-mediated intestinal inflammation by protecting them

210 important genes conferring sensitivity to T cell-mediated killing in vitro.

211 Natural killer (NK) cell-mediated killing involves the membrane fusion of pr

212 ntation, and in initiating specific CD8(+) T-cell-mediated killing of antigen-loaded target cells in

213 s, destroyed tumor fibrosis, and unleashed T cell-mediated killing of cancer cells.

214 microbial-derived D-lactate promotes Kupffer-cell-mediated killing of circulating pathogens.

215 eatments, possessing the ability to elicit T cell-mediated killing of tumor cells and prevent disease

216 id tumors that are typically resistant to NK cell-mediated killing, demonstrating the feasibility of

217 ckdown sensitizes tumor cells to cytotoxic T cell-mediated killing, improving CAR T cell therapy.

218 release of lytic granule contents during NK cell-mediated killing.

219 sistance to lysostaphin degradation and host cell-mediated killing.

220 ibodies to enhance NK cell activation and NK cell-mediated killing.

221 tumor cells, leading to the resistance to T cell-mediated killing.

222 olecules that serve to protect cells from NK cell-mediated killing.

223 rotection, that mainly correlated with low T cell mediated Leishmania-specific IL-4 and IL-10 respons

224 Our results reveal that active cell-mediated matrix recruitment through actomyosin forc

225 Although cell-mediated matrix remodeling that occurs within these

226 For T cell-mediated memory responses to SARS-CoV-2, it is rele

227 A heterogeneous magnitude of CD4(+) T cell-mediated memory responses was observed in regard to

228 activity, and provision of help for CD8(+) T cell-mediated memory responses, limiting host defense an

229 ation of macrophages and natural killer (NK) cell-mediated metastasis control.

230 Glp1r agonism was tested in a nondiabetic, T-cell-mediated murine model of nephrotoxic serum nephriti

231 In agreement with our in vitro data, mast cell-mediated passive cutaneous anaphylaxis and passive

232 wever, the underlying mechanisms of CD4(+) T cell-mediated pathogenesis are largely unknown.

233 which noncoding risk variants influence the cell-mediated pathogenesis of immune-mediated disease (I

234 (acetate, propionate, and butyrate) on mast cell-mediated pathology and human mast cell activation,

235 ogic and inflammatory components of CD8(+) T cell-mediated pathology.

236 at each point in space, we find a horizontal-cell-mediated pathway similar to that found in mammals.

237 opulations which may have implications for T cell-mediated processes such as inflammation and immuno-

238 e, we investigated whether B cells inhibit T cell-mediated protection against Brucella Using B and T

239 s show a key role for PI3K signaling in Treg cell-mediated protection against CNS inflammation.

240 Cell-mediated protection from liver-stage malaria relies

241 dy depletion approach, we confirmed CD4(+) T cell-mediated protective immunity and a CD8(+) T cell-de

242 Cutaneous T cell-mediated reactions classically occur more than 6 ho

243 ed dystrophic muscle enhances the donor stem cell-mediated regeneration.

244 cipients had a relatively low incidence of T cell-mediated rejection (9.2%) and antibody-mediated rej

245 d on renal tubular epithelial cells by acute cell-mediated rejection (ACR.

246 clinical importance of subclinical, early T cell-mediated rejection (Banff TCMR 1A and borderline le

247 ted the effect of clinical and subclinical T cell-mediated rejection (C-TCMR and SC-TCMR) on allograf

248 Subclinical T cell-mediated rejection (subTCMR) is commonly found afte

249 4 groups: normal "R1(normal) " (N = 129), T cell-mediated rejection (TCMR) "R2(TCMR) " (N = 37), ear

250 arteriolitis/vasculitis in the setting of T cell-mediated rejection (TCMR) and antibody-mediated rej

251 esponses in renal allografts with those in T-cell-mediated rejection (TCMR) and chronic antibody-medi

252 ts to the criteria for chronic active (CA) T cell-mediated rejection (TCMR), borderline, and antibody

253 total of 9 patients suffered an episode of T-cell-mediated rejection (TCMR).

254 s was to establish diagnostic criteria for T-cell-mediated rejection (TCMR).

255 hort of native kidney BKVN (n = 5) vs pure T cell-mediated rejection (TCMR; n = 10).

256 ecular phenotype of both acute and chronic T cell-mediated rejection and antibody-mediated rejection

257 i-INT was predicted by prior T-cell-mediated rejection and BKVAN, human leukocyte antig

258 T cell-mediated rejection episodes tended to be relatively

259 T cell-mediated rejection seems to form a continuum of all

260 allograft specimens showed grade 2A acute T cell-mediated rejection, cortical infarction, or acute t

261 Initially overlooked in favor of T cell-mediated rejection, the importance of the humoral a

262 tial inflammation (i-INT) is the driver of T-cell-mediated rejection.

263 nd a transcriptional profile of attenuated T cell-mediated rejection.

264 A-DSA status but was caused by concomitant T cell-mediated rejection.

265 rapid rebound of antibodies, with profound T cell-mediated rejection.

266 led a substantially high incidence of acute, cell-mediated rejection.

267 Cell-mediated remodeling of extracellular matrix (ECM) p

268 ells in regulating the balance between CD8 T cell-mediated resistance against respiratory viral infec

269 tial for dectin-1-dependent activation of NK cell-mediated resistance to metastasis.

270 Specifically, IL18 induced a Th2 cell-mediated response in the absence of IL12.

271 gp100 and WT1 tumor antigen induced a CD8+ T-cell-mediated response in tumor-transplanted syngeneic m

272 inflammation and simultaneously induce a Th2 cell-mediated response via IL18.

273 ic in mice and elicites a robust humoral and cell-mediated response.

274 activation of T cells and no increase in Th2 cell-mediated responses compared with control mice.

275 fy Ptpn2 as a negative regulator of CD8(+) T cell-mediated responses to LCMV Clone 13 viral infection

276 mune profiles, specifically interferon and T cell-mediated responses.

277 ecular and cellular analyses of cells from T-cell-mediated RJ and nonrejected kidney transplant patie

278 llowing skin transplantation, the donor mast cell-mediated senescence in FRCs was associated with col

279 , as shown in vitro, and suggests that PV(+) cell-mediated short-term synaptic depression influences

280 RNA-seq and follow-up analyses showed cancer cell-mediated SIRT1 loss induced NF-kappaB signaling in

281 filtration contributes to autoreactive CD4 T cell-mediated skin autoinflammation.

282 utrophils is required for autoreactive CD4 T cell-mediated skin disease pathogenesis and that the NLR

283 MHCII, represents a novel pathway for T(reg) cell-mediated suppression and may be a mechanism by whic

284 cytokine IL-35 that was required for T(reg) cell-mediated suppression of gammadelta T cells.

285 ons of Rorgammat; Foxp3 expression and iTreg cell-mediated suppression remained intact.

286 onses to interleukin (IL)-2 and regulatory T cell-mediated suppression, the composition of the B-cell

287 severity, in association with reduced T(reg) cell-mediated suppression.

288 to 1) inhibit bone marrow-derived dendritic cell-mediated T cell functions and reduce serum anti-dsD

289 omponent of cytotoxic granules involved in T cell-mediated target cell-killing, and monomeric teal fl

290 Human leukocyte antigen (HLA)-independent, T cell-mediated targeting of cancer cells would allow immu

291 microenvironment stiffness leads to stromal cell-mediated TGF-beta family signaling relying on the i

292 BNZ-2 might be used to prevent cytotoxic T-cell-mediated tissue damage in complex immune disorders

293 that re-creates genetic susceptibility to T-cell-mediated tissue injury as observed in a mouse model

294 lls, ii) microscale materials can facilitate cell-mediated transport and serve as artificial antigen-

295 nd anti-PD-L1 synergistically improves CAR-T cell-mediated tumor control and survival, providing a st

296 okine-induced antiproliferative effects in T-cell-mediated tumor control.

297 tein 176B (TMEM176B) contributes to CD8(+) T cell-mediated tumor growth inhibition by unleashing infl

298 D8(+) T cells is critical to the design of T cell-mediated vaccines.

299 30), with functional implications both for T cell-mediated viral control and immunopathology.

300 mediated cytotoxicity and antibody-dependent cell-mediated virus inhibition) were observed in serum o